Neal Fitzpatrick Joins ImmunoTek as Chief Commercial Officer

Neal Web Wide

ImmunoTek Bio Centers is thrilled to announce Neal Fitzpatrick’s appointment as the new Chief Commercial Officer. With an extensive background in the biopharmaceutical sector, Neal brings over 30 years of experience to this pivotal role.

In his new position, Neal will spearhead ImmunoTek’s business development efforts, focusing on driving new business opportunities, including securing orders for new plasma centers and normal source plasma. This appointment comes at a crucial time as the company navigates post-pandemic shifts in demand.

Neal’s track record of success includes serving as Vice President of Sales at ADMA Biologics, where he significantly expanded the immune globulin franchise and doubled the brand’s presence annually. Before his tenure at ADMA, Neal was Vice President of Commercial Operations at Kedrion Biopharma, where he played a key role in scaling operations in North America and launching multiple plasma-derived products, enhancing Kedrion’s market position.

“We are thrilled to welcome Neal to the ImmunoTek team,” said Marvin Dyke, President of ImmunoTek. “His wealth of experience and proven track record in the biopharmaceutical industry make him the perfect fit to lead our business development efforts as we continue to grow and expand our presence in the market.”

Outside his professional endeavors, Neal and his wife, Kathy, enjoy a vibrant outdoor life and cherish moments with their four grandchildren.

Please join us in warmly welcoming Neal to the ImmunoTek family. His expertise and leadership will undoubtedly play a significant role in achieving our ambitious growth plans, leaving a lasting impact across the company.